Efficacy of Mabthera (anti CD20 Ab) in patients with relapsed/progressed Hairy cell leukemia.

被引：0
|
作者：
Lauria, F
Lenoci, M
Annino, L
Raspadori, D
Marotta, G
Bocchia, M
Gentili, S
La Manda, M
Marconcini, S
Zinzani, PL
机构：
[1] Univ Siena, I-53100 Siena, Italy
[2] Univ La Sapienza, Rome, Italy
[3] Seragnoli, Bologna, Italy
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
592
引用
收藏
页码：138A / 138A
页数：1
相关论文
共 50 条
  • [41] The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia
    Serbanica, Andreea Nicoleta
    Popa, Delia Codruta
    Caruntu, Constantin
    Pasca, Sergiu
    Scheau, Cristian
    Serbanica, Ionut Vlad
    Suciu, Raluca
    Tica, Valeria
    Busescu, Elisa
    Cima, Luminita Nicoleta
    Jardan, Cerasela
    Dragomir, Mihaela
    Coriu, Daniel
    Colita, Andrei
    Colita, Anca
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [42] PC-002 (Sepantronium Bromide) Enhances the Antitumor Efficacy of Anti-CD20 Antibody By CD20 Upregulation
    Jiang, Vernon
    Li, Xiang
    He, Na
    Lv, Yan
    Wang, Haiyue
    Zhang, Ming
    Zhai, Heiyan
    Yang, Zhen
    Yang, Yi
    Guo, Dagang
    Cao, Zhixiang
    Chen, Yiyou
    BLOOD, 2024, 144 : 5822 - 5823
  • [43] HDAC6 Inhibition Increases Translation of CD20 mRNA and Potentiates the Efficacy of Anti-CD20 Immunotherapy
    Bobrowicz, Malgorzata
    Stachura, Joanna
    Dwojak, Michal
    Domagala, Antoni
    Pyrzynska, Beata
    Berthel, Elise
    Venezia, Nicole Dalla
    Siernicka, Marta
    Firczuk, Malgorzata
    Winiarska, Magdalena
    BLOOD, 2016, 128 (22)
  • [44] Treatment with interferon-alpha restores the skewed T cell repertoire in patients with hairy cell leukemia.
    KluinNelemans, JC
    Kester, MGD
    vandeCorput, L
    Boor, PPC
    Landegent, JE
    vanDongen, JJM
    Willemze, R
    Falkenburg, JHF
    BLOOD, 1996, 88 (10) : 952 - 952
  • [45] CLINICOPATHOLOGICAL IMPACT OF CD20 EXPRESSION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Aref, Salah
    Fouda, Manal
    Aziz, Shereen Abdel
    Mohamed, Deina
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 : 11 - 11
  • [46] CD5+, CD11C+, CD20+ HAIRY-CELL LEUKEMIA
    HEIMANN, PS
    VARDIMAN, JW
    STOCK, W
    PLATANIAS, LC
    GOLOMB, HM
    BLOOD, 1991, 77 (07) : 1617 - 1618
  • [47] Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas
    Schuster, Stephen J.
    Huw, Ling-Yuh
    Bolen, Christopher R.
    Maximov, Victor
    Polson, Andrew G.
    Hatzi, Katerina
    Lasater, Elisabeth A.
    Assouline, Sarit E.
    Bartlett, Nancy L.
    Budde, L. Elizabeth
    Matasar, Matthew J.
    Koeppen, Hartmut
    Piccione, Emily C.
    Wilson, Deanna
    Wei, Michael C.
    Yin, Shen
    Penuel, Elicia
    BLOOD, 2024, 143 (09) : 822 - 832
  • [48] Clinical relevance of circulating CD20 (cCD20) in patients with chronic lymphocytic leukemia (CLL).
    Manshouri, T
    Saffer, H
    Keating, M
    Albitar, M
    BLOOD, 2000, 96 (11) : 369A - 369A
  • [49] Relapsed follicular lymphoma.: Response to Fludarabine-Mitoxantrone regimen and monoclonal anti CD20 (Rituximab).
    Giraldo, P
    Pelegrín, F
    Palomera, L
    Recasens, V
    Nájera, MJ
    Puente, F
    Perdiguer, L
    Rubio-Félix, D
    BLOOD, 2000, 96 (11) : 730A - 730A
  • [50] Differential tumor cell targeting of anti-HER2 (Herceptin®) and anti-CD20 (Mabthera®) coupled nanoparticles
    Cirstoiu-Hapca, A.
    Bossy-Nobs, L.
    Buchegger, F.
    Gurny, R.
    Delie, F.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 331 (02) : 190 - 196
12345